SIRT3 and obesity due to melanocortin 4 receptor deficiency: Thus, SIRT3 has been suggested as a potential therapeutic target for preventing the development of diet‐induced obesity and mitigating its pathological effects, including obesity‐related cardiac dysfunction (Zeng et al., 2015).